Pfizer (NY:<a title="Quote for Pfizer" href="https://markets.financialcontent.com/dptribune/quote?Symbol=NY%3APFE">PFE )

Pfizer Stock Draws Focus On Report Of $7.3B Deal Plan For Metsera Buyout As Obesity Drug Race With Lilly, Novo Heats Up ↗

September 22, 2025

Via Stocktwits

P/E Ratio Insights for Pfizer ↗

September 18, 2025

Via Benzinga

Gold Gains Over 1%; Quantum Computing Shares Plunge ↗

September 22, 2025

Via Benzinga

IBD 50's Tempus AI Hits Record High On Yet Another FDA Clearance ↗

September 22, 2025

The company is focusing on RNA sequencing as a means of assisting with drug development.

The deal follows two high-profile failures for Pfizer, which is trying to broaden its small pipeline in weight loss.

Topics Artificial Intelligence Intellectual Property

Pfizer Claws Deeper Into The Obesity Space With $4.9 Billion Metsera Deal ↗

September 22, 2025

Pfizer will buy Metsera for $4.9 billion plus milestone payments, adding incretin, amylin, and oral obesity drug candidates to its pipeline.

Pfizer Tries To Revitalize Obesity Portfolio With $5 Billion Matsera Deal ↗

September 22, 2025

Via Benzinga

3 Dirt-Cheap Stocks to Buy Right Now ↗

September 22, 2025

These stocks share several common denominators, including attractive valuations.

Pfizer Reportedly Nears Metsera Acquisition Deal: PFE Stock Climbs In Monday Pre-Market ↗

Topics Intellectual Property

September 22, 2025

Pfizer Inc. (NYSE: PFE) stock climbed 1.87% in Monday pre-market amid reports that the company on the verge of acquiring Metsera Inc. (NASDAQ: MTSR), a developer of anti-obesity drugs.

Via Benzinga

Metsera Stock Surges 59% Pre-Market After Pfizer Confirms Acquisition – Here Are The Details ↗

September 22, 2025

The upfront purchase price of $47.50 per share implies a premium of 43% from Metsera’s closing share price on Friday.

Via Stocktwits

Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio

September 22, 2025

From Pfizer Inc.

Via Business Wire

Trump Administration To Unveil Tylenol-Autism Review, Tout This Drug As Potential Treatment: Report ↗

September 22, 2025

Trump administration to announce concerns about Tylenol use in pregnancy and potential treatment for autism, in line with President's priority.

Via Benzinga

Topics Government

3 Bargain Stocks for Investors on a Budget ↗

September 21, 2025

If every one of your dollars counts, make sure you're getting the biggest possible bang for your buck.

There is a "for sale" sign on the sector, and these two stocks look particularly attractive at their current levels.

Topics Economy

Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon ↗

September 20, 2025

A high yield is only one part of the story when it comes to picking dividend stocks.

Topics Government Intellectual Property World Trade

What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill ↗

September 20, 2025

These stocks are bargains now. But they probably won't be by the end of this decade.

Topics Intellectual Property

Prediction: These Could Be the Best-Performing Value Stocks Through 2030 ↗

September 20, 2025

The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market

Topics Artificial Intelligence Intellectual Property

September 19, 2025

The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving...

Moderna stock toppled Friday after advisors to the CDC and Prevention ended the universal recommendation for Covid vaccines.

Topics Artificial Intelligence Economy Intellectual Property

CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids ↗

September 19, 2025

Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.

Stay informed about the most active stocks in the S&P500 index on Friday's session. ↗

September 19, 2025

Via Chartmill

Eli Lilly Poised for Blockbuster Q3 2025 with Skyrocketing EPS and Revenue Projections

September 19, 2025

Pharmaceutical giant Eli Lilly and Company (NYSE:LLY) is gearing up for a stellar third quarter of 2025, with analysts projecting massive earnings per share (EPS) and revenue growth. The optimistic...

GLP-1 Titans Clash: Eli Lilly Challenges Novo Nordisk's Dominance in a Spiraling Market Battle

Topics Artificial Intelligence Economy Intellectual Property

September 19, 2025

The pharmaceutical industry is witnessing an unprecedented showdown as Eli Lilly (NYSE: LLY) rapidly encroaches upon Novo Nordisk's (NYSE: NVO) long-held lead in the burgeoning GLP-1 (glucagon-like...

Eli Lilly and Company (NYSE: LLY) has unveiled its groundbreaking TuneLab Platform, an artificial intelligence (AI) and machine learning (ML) initiative designed to democratize advanced drug discovery...

Lilly's AI Gambit: TuneLab Poised to Reshape Biotech Drug Discovery Landscape

September 19, 2025

Everything is going great for the stock market right now. But a plot twist could be on the way.

Topics Animal Testing Artificial Intelligence Intellectual Property

3 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗

September 19, 2025

Viking's stock took a beating last month, and it has opened up a glorious buying opportunity for investors.

Topics Economy

Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months ↗

September 19, 2025

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?' ↗

Topics Bankruptcy

September 18, 2025

Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps,...

Via Benzinga

The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut ↗

September 18, 2025

The reworked ACIP will make its debut Friday when the panelists weigh the suite of new Covid boosters.

Washington D.C. - The U.S. Federal Reserve finds itself at a critical juncture, facing an economic environment that is increasingly raising the specter of "stagflation" – a challenging combination of...

Topics Government

Federal Reserve Navigates Stagflationary Headwinds with Dovish Pivot

September 18, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...

Topics Economy Supply Chain World Trade

1 Large-Cap Stock Worth Your Attention and 2 We Find Risky

September 18, 2025

Via StockStory

The Specter of Stagflation: Is the Economy Headed for Stagnant Growth and High Inflation?

September 17, 2025

The U.S. Federal Reserve’s recent decision to cut interest rates has sent a tremor of concern through financial markets, sparking fears of a potential return to stagflation—an economic phenomenon...